Breast cancer quality standard

NICE quality standards [QS12] Published date:

Quality statement 7: Staging

Quality statement

People with early invasive breast cancer do not undergo staging investigations for distant metastatic disease in the absence of symptoms.

Quality measure

Structure: Evidence of local arrangements and written clinical protocols to ensure that people with early invasive breast cancer do not undergo staging investigations for distant metastatic disease in the absence of symptoms.

Process: Proportion of people with early invasive breast cancer who do not undergo staging investigations for distant metastatic disease in the absence of symptoms.

Numerator – the number of people in the denominator who do not undergo staging investigations for distant metastatic disease.

Denominator – the number of people with early invasive breast cancer who have no symptoms suggestive of distant metastatic disease.

What the quality statement means for each audience

Service providers ensure systems are in place so that people with early invasive breast cancer do not undergo staging investigations for distant metastatic disease in the absence of symptoms.

Healthcare professionals ensure that people with early invasive breast cancer do not undergo staging investigations for distant metastatic disease in the absence of symptoms.

Commissioners ensure they commission services in which people with early invasive breast cancer do not undergo staging investigations for distant metastatic disease in the absence of symptoms.

People with early invasive breast cancer do not undergo investigations for cancer elsewhere in the body if they have no symptoms that the cancer has spread.

Data source

Structure: Local data collection.

Process: Local data collection.

Definitions

Staging is indicated for inflammatory, locally advanced or recurrent breast cancer.

Get involved